Does MEGLUMINE Cause Peripheral venous disease? 246 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 246 reports of Peripheral venous disease have been filed in association with MEGLUMINE. This represents 42.1% of all adverse event reports for MEGLUMINE.
246
Reports of Peripheral venous disease with MEGLUMINE
42.1%
of all MEGLUMINE reports
246
Deaths
238
Hospitalizations
How Dangerous Is Peripheral venous disease From MEGLUMINE?
Of the 246 reports, 246 (100.0%) resulted in death, 238 (96.7%) required hospitalization, and 243 (98.8%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 246 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which MEGLUMINE Alternatives Have Lower Peripheral venous disease Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE